Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01950637 · ClinicalTrials.gov registry record
GAPP 2 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Type 2 Diabetes Mellitus
A clinical trial, sponsored by Novo Nordisk A/S.
- Completed
- Registry status
- 4,000
- Enrollment target
NCT01950637 is a clinical trial that has completed, run by Novo Nordisk A/S. The registered enrollment target is 4,000 participants.
The verdict
NCT01950637 has completed, sponsored by Novo Nordisk A/S.
- COMPLETED
- Registry status
- 4,000 participants
- Enrollment target
Study Summary
This study is conducted Asia, Europe and North America. The aim of this study is to describe insulin therapy adherence and the burden of non-adherence on patient functioning, well-being and diabetes management.
Interventions
- BEHAVIORAL survey
- BEHAVIORAL No treatment given
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 2012-01 |
| Est. Completion | 2013-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01950637
The ClinicalTrials.gov registry entry for NCT01950637 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 4,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novo Nordisk A/S, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which survey is the first listed.
NCT01950637 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01950637 about?
NCT01950637 is a clinical study titled "GAPP 2 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Type 2 Diabetes Mellitus". This study is conducted Asia, Europe and North America. The aim of this study is to describe insulin therapy adherence and the burden of non-adherence on patient functioning, well-being and diabetes management.
What is the current status of trial NCT01950637?
This trial is currently completed. The enrollment target is 4,000 participants. The study started on 2012-01. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01950637?
The interventions under investigation include: survey (BEHAVIORAL), No treatment given (BEHAVIORAL).
Who is sponsoring clinical trial NCT01950637?
This trial is sponsored by Novo Nordisk A/S, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.